Does Subtotal Cholecystectomy Rate for Acute Cholecystitis Change With a Previous ERCP?
NCT ID: NCT05728073
Last Updated: 2023-09-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
470 participants
OBSERVATIONAL
2022-12-10
2023-01-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Post-ERCP Cholecystectomy. How ERCP and ERCP-related Variables Effect the Outcomes?
NCT06388525
Prolonged Versus Delayed Laparoscopic Cholecystectomy for Acute Cholecystitis
NCT05736003
Effect Of Early Versus Delayed Laparoscopic Cholecystectomy In Patients With Grade II Cholecystitis
NCT05352087
Emergency Versus Elective Cholecystectomy in Acute Cholecystitis in the Era of Laparoscopy.
NCT05502744
Subserosal Laparoscopic Cholecystectomy
NCT05770128
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Primary outcome was subtotal cholecystectomy rate. Secondary outcomes were conversion to open, complications and serious complications. Within examining demographic findings, operative records (rates for subtotal cholecystectomy and conversion to open, operative duration) and follow-up results (postoperative complications, serious complications, length of hospital stay and mortality) for all cases were investigated. Complications that Clavien-Dindo Score ≥ 3 accepted as serious complication. Intraoperative detection of gallbladder perforation was also noted and included in comparison. Any biliary tract complication that needed any percutaneous or endoscopic intervention to handle was named as "biliary leak" in the study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard (non-ERCP) Group
Patients who underwent surgery for acute cholecystitis without a previous ERCP history.
No interventions assigned to this group
ERCP group
Patients who underwent surgery for acute cholecystitis with a previous ERCP history.
ERCP
Patients separated to two groups according to having a ERCP history before the operation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ERCP
Patients separated to two groups according to having a ERCP history before the operation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Being diagnosed with malignity after histopathological evaluation
* Being operated just before one week after ERCP or after more than six weeks after ERCP
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bakirkoy Dr. Sadi Konuk Research and Training Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Turgut Donmez
Ass. Prof. Dr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mehmet Karabulut
Role: STUDY_CHAIR
University of Health Sciences, Bakirkoy Dr.Sadi Konuk Training and Research Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bakırkoy Dr.Sadi Konuk Training and Research Hospital
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20230205
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.